share_log

EFFECT: Others

EFFECT: Others

EFFECT:其他
美股sec公告 ·  06:06
Moomoo AI 已提取核心信息
The United States Securities and Exchange Commission (SEC) has declared that the Form S-3 filed by 60 Degrees Pharmaceuticals, Inc. is now effective as of July 18, 2024, at 9:00 A.M. The Form S-3 is a registration statement that allows companies to issue various securities to the public. The effectiveness of this form indicates that 60 Degrees Pharmaceuticals has met all the necessary regulatory requirements to potentially offer securities to investors. The company's CIK number is 0001946563, and the file number for this particular form is 333-280796.
The United States Securities and Exchange Commission (SEC) has declared that the Form S-3 filed by 60 Degrees Pharmaceuticals, Inc. is now effective as of July 18, 2024, at 9:00 A.M. The Form S-3 is a registration statement that allows companies to issue various securities to the public. The effectiveness of this form indicates that 60 Degrees Pharmaceuticals has met all the necessary regulatory requirements to potentially offer securities to investors. The company's CIK number is 0001946563, and the file number for this particular form is 333-280796.
美国证券交易委员会(SEC)宣布,60 Degrees Pharmaceuticals, Inc.提交的S-3表格现已于2024年7月18日上午9:00生效。S-3表格是一种注册声明,允许公司向公众发行各种证券。这个表单的生效意味着60 Degrees Pharmaceuticals已经满足了所有必要的监管要求,有可能向投资者发行证券。该公司的CIk号码为0001946563,这个特定表格的文件号为333-280796。
美国证券交易委员会(SEC)宣布,60 Degrees Pharmaceuticals, Inc.提交的S-3表格现已于2024年7月18日上午9:00生效。S-3表格是一种注册声明,允许公司向公众发行各种证券。这个表单的生效意味着60 Degrees Pharmaceuticals已经满足了所有必要的监管要求,有可能向投资者发行证券。该公司的CIk号码为0001946563,这个特定表格的文件号为333-280796。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息